1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > Stem Cell Therapeutics Markets

Stem Cell Therapeutics Markets

  • October 2014
  • -
  • Kalorama Information
  • -
  • 214 pages

Summary

Table of Contents

Search Inside

There is great interest in stem cells because they have potential to replace defective or damaged cells resulting from a variety of disorders and injuries, leading to a range of new regenerative therapies. Stem cells have become effective tools in blood diseases, musculoskeletal diseases, digestive disorders and many other areas.

Kalorama Information’s Stem Cell Therapeutics Markets conducts in-depth research into the stem cell market opportunity by assessing current technology performance, new developments, pricing trends and government positions on the topic. A combination approach – using both a bottom-up model and comparing data with a top-down analysis – was used to determine market size and market forecasts.

Over the next several years, as researchers introduce a growing variety of technologies, products and services based upon stem cells, revenues related to stem cell therapies will increase dramatically. New therapeutic applications of stem cells could potentially be realized in all of the following disease segments:
Blood and Blood-Forming Organs
Circulatory System
Endocrine and Metabolic System and Immunity Disorders
Eye
Gastrointestinal System
Musculoskeletal System and Connective Tissue Disorders
Neoplasms
Nervous System
Respiratory System
Skin and Subcutaneous Tissues
There are more than 4,000 research projects underway for stem cell therapies throughout the world. About a dozen companies worldwide are currently evaluating stem cell therapies in late stage clinical trials. Companies discussed in this report include those which have registered trials in Phase I through Phase III development. These include:
Aastrom Biosciences
Advanced Cell Technology
Anterogen
Antria
apceth
Arteriocyte
Athersys
Baxter
BioCardia
Bioheart
BrainStorm Cell
Capricor
Celgene
Cytomedix
Cytori
Gamida Cell
GlaxoSmithKline
ISCO
Intrexon
ISTO
Medipost
Mesoblast
NeoStem
Neuralstem
Pharmicell
Pluristem
ReNeuron
SanBio
StemCells
Stemedica Cell
Stempeutics
Targazyme
TiGenix
ViaCyte

Information for this report was gathered using both primary and secondary research. Primary research methods include telephone interviews and email correspondence with company representatives, researchers and physicians; secondary sources include comprehensive research of company reports and literature, government documents and databases, research journals and reports and general medical and business journals. Forecast dollar figures represent the estimated global market and are expressed in current dollars. Forecasts are provided through 2025. The size of each market segment refers to manufacturers’ revenues.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
Stem Cell Therapy Market by Type, Therapeutic Application, Cell Source - Global Forecasts to 2021

Stem Cell Therapy Market by Type, Therapeutic Application, Cell Source - Global Forecasts to 2021

  • $ 5650
  • Industry report
  • February 2017
  • by MarketsandMarkets

The global stem cell therapy market is estimated to grow at a CAGR of 11.0% during 2016 to 2021 to reach USD 145.8 million by 2021. Growth in the global stem cell therapy market is driven by factors such ...

Human Embryonic Stem Cells (hESC) Market Analysis By Application (Regenerative Medicines, Stem Cell Biology Research, Tissue Engineering, Toxicology Testing), By Country (U.S., UK, Germany, Japan, China), And Segment Forecasts, 2014 - 2025

Human Embryonic Stem Cells (hESC) Market Analysis By Application (Regenerative Medicines, Stem Cell Biology Research, Tissue Engineering, Toxicology Testing), By Country (U.S., UK, Germany, Japan, China), And Segment Forecasts, 2014 - 2025

  • $ 4950
  • Industry report
  • February 2017
  • by Grand View Research

The global human embryonic stem cells (hESCs) market is anticipated to reach USD 1.06 billion by 2025, according to a new report by Grand View Research, Inc. Application of hESCs as a promising donor source ...

Global Regenerative Medicine Market Analysis & Forecast to 2021; Stem Cells, Tissue Engineering, BioBanking & CAR-T Industries

Global Regenerative Medicine Market Analysis & Forecast to 2021; Stem Cells, Tissue Engineering, BioBanking & CAR-T Industries

  • $ 4900
  • Industry report
  • May 2017
  • by Kelly Scientific Publications

This report provides a comprehensive overview of the size of the regenerative medicine market, segmentation of the market (stem cells, tissue engineering and CAR-T therapy), key players and the vast potential ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.